ArticlePlastic and reconstructive surgery. Global open2026
Microneedling Combined With Biomimetic Peptides for Burn Scar Improvement: A Prospective Study.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertrophic scarring commonly follows burn injury, resulting from persistent inflammation, abnormal fibroblast activity, and excessive extracellular matrix deposition, leading to functional limitation and aesthetic impairment. Despite multimodal management, outcomes remain variable. Biomimetic peptides can modulate cellular pathways involved in tissue repair, whereas microneedling enhances transdermal delivery and stimulates dermal remodeling. Methods: This prospective, single-arm, interventional, before-and-after clinical study evaluated patients with hypertrophic burn scars treated with microneedling-assisted delivery of biomimetic peptides. Participants underwent 5 treatment sessions at 12-week intervals, followed by a final follow-up assessment 12 weeks after the last session (week 60). Scar characteristics were assessed at baseline and during follow-up using validated instruments, including the Vancouver Scar Scale and the Patient and Observer Scar Assessment Scale. Scar-related symptoms and functional limitation were also recorded. Safety was monitored through prospective reporting of adverse events. Pre- and posttreatment outcomes were compared within subjects. Results: Following therapy, improvement was observed across multiple scar domains, including pigmentation, pliability, thickness, and vascularity, reflected by reductions in Vancouver Scar Scale and Patient and Observer Scar Assessment Scale observer scores. Patient-reported outcomes showed parallel improvements in discomfort, pruritus, and perceived stiffness, accompanied by gains in functional mobility. No serious adverse events or treatment discontinuations occurred. Conclusions: Microneedling-assisted biomimetic peptide therapy was associated with meaningful improvements in scar appearance and patient-reported function in hypertrophic burn scars. This minimally invasive approach may complement comprehensive scar rehabilitation. Controlled studies are needed to confirm efficacy and refine protocols.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.